Dr. Akbay was awarded the IASLC Young Investigator Award for 2015-2016. Dr. Akbay’s research is focused on elucidating immune related mechanisms that drive lung cancer. Her unique combination of skills in cancer biology and tumor immunology makes her suitable to study the proposed project of overcoming resistance to EGFR inhibitors with immunotherapy. Dr. Akbay will work on this project in close collaboration with Drs. Janne and Johnson, who are leaders in the field for initiating rationally designed lung cancer clinical trials.